Donor-Recipient Weight Match in Pediatric Heart Transplantation: Liberalizing Weight Matching with Caution

Ming Chen1, Li Xu1,2, Wenjing Yu3

  • 1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430015, China.

Insights

Expanding donor and recipient weight ratios (DRWR) to over 30% is feasible in pediatric heart transplantation (HTx). This study found no significant survival differences, supporting wider DRWR acceptance in China.

Area of Science:

  • Cardiology
  • Transplantation Surgery
  • Pediatric Medicine

Background:

  • Donor heart scarcity necessitates expanding donor criteria in heart transplantation (HTx).
  • Data on the feasibility of donor and recipient weight ratios (DRWR) exceeding 30% in pediatric HTx, particularly in China, remains limited.
  • The upper limit for acceptable DRWR in pediatric HTx is debated, with potential risks associated with wider ratios.

Purpose of the Study:

  • To evaluate the safety and feasibility of utilizing donor hearts with a donor and recipient weight ratio (DRWR) greater than 30% in pediatric heart transplantation (HTx).
  • To analyze the impact of expanded DRWR on survival outcomes in pediatric heart transplant recipients.

Main Methods:

  • A retrospective analysis of 78 pediatric patients (<18 years) who underwent HTx between 2015 and 2020.
  • Patients were categorized into two groups based on DRWR: >30% and ≤30%.
  • Univariate, multivariate, and Kaplan-Meier survival analyses were performed to compare outcomes between groups.

Main Results:

  • No significant differences in one-year, three-year, or five-year survival rates were observed between the DRWR >30% and ≤30% groups.
  • The study suggests that expanding the DRWR to over 30% is acceptable in pediatric HTx.

Conclusions:

  • The expansion of donor and recipient weight ratios (DRWR) to over 30% is a viable strategy for pediatric heart transplantation (HTx) in China.
  • While a liberal upper DRWR boundary (e.g., >200%) may serve as a last resort, its application requires careful consideration and caution.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
66
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
531
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
81
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
516